Cargando…
Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma
BACKGROUND: Cerebrospinal fluid (CSF) has been demonstrated as a better source of circulating tumor DNA (ctDNA) than plasma for brain tumors. However, it is unclear whether whole exome sequencing (WES) is qualified for detection of ctDNA in CSF. The aim of this study was to determine if assessment o...
Autores principales: | Duan, Hao, Hu, Ji-Long, Chen, Zheng-He, Li, Jue-Hui, He, Zhen-Qiang, Wang, Zhen-Ning, Zhang, Guan-Hua, Guo, Xiao-Yu, Liang, Lun, Mou, Yong-Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339330/ https://www.ncbi.nlm.nih.gov/pubmed/32558704 http://dx.doi.org/10.1097/CM9.0000000000000843 |
Ejemplares similares
-
Identification of Genetic Alterations in Rapid Progressive Glioblastoma by Use of Whole Exome Sequencing
por: Khan, Imran, et al.
Publicado: (2023) -
A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling
por: Guo, Xiao-Yu, et al.
Publicado: (2021) -
Challenges in cerebrospinal fluid shunting in patients with glioblastoma
por: Hong, Bujung, et al.
Publicado: (2018) -
Diagnostic value of circulating tumor cells in cerebrospinal fluid
por: Ning, Mu, et al.
Publicado: (2016) -
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma
por: Akers, Johnny C., et al.
Publicado: (2017)